Hongmei Li

6.0k total citations · 2 hit papers
165 papers, 4.7k citations indexed

About

Hongmei Li is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Hongmei Li has authored 165 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Molecular Biology, 40 papers in Oncology and 23 papers in Cancer Research. Recurrent topics in Hongmei Li's work include Natural product bioactivities and synthesis (9 papers), Ubiquitin and proteasome pathways (8 papers) and Magnolia and Illicium research (8 papers). Hongmei Li is often cited by papers focused on Natural product bioactivities and synthesis (9 papers), Ubiquitin and proteasome pathways (8 papers) and Magnolia and Illicium research (8 papers). Hongmei Li collaborates with scholars based in China, United States and Australia. Hongmei Li's co-authors include Xiao Zhu, Tao Tao, Zhilin Zou, Kaeko Iiyama, Myron I. Cybulsky, Motoi Iiyama, Benjamin D. Medoff, Dong Wan Seo, William G. Stetler‐Stevenson and Beiyang Wei and has published in prestigious journals such as Cell, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Hongmei Li

157 papers receiving 4.6k citations

Hit Papers

mTOR signaling pa... 1999 2026 2008 2017 2020 1999 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
    2020 662 citations Hongmei Li et al. profile →
  2. Patterns of Vascular Cell Adhesion Molecule-1 and Intercellular Adhesion Molecule-1 Expression in Rabbit and Mouse Atherosclerotic Lesions and at Sites Predisposed to Lesion Formation
    1999 512 citations Hongmei Li et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongmei Li China 35 2.6k 937 841 751 383 165 4.7k
Borhane Annabi Canada 41 2.2k 0.8× 1.2k 1.3× 1.1k 1.3× 516 0.7× 324 0.8× 151 4.8k
Yangfu Jiang China 31 2.7k 1.0× 1.2k 1.3× 1.1k 1.4× 525 0.7× 456 1.2× 70 4.9k
Chiao‐Wen Lin Taiwan 39 2.7k 1.0× 1.4k 1.5× 905 1.1× 449 0.6× 307 0.8× 176 4.4k
Haiying Chen United States 31 2.7k 1.1× 764 0.8× 1.0k 1.2× 476 0.6× 301 0.8× 129 4.8k
Sanjay Kumar United States 25 3.5k 1.4× 700 0.7× 1.2k 1.4× 1.0k 1.4× 242 0.6× 87 6.3k
Aree Moon South Korea 42 2.8k 1.1× 1.1k 1.1× 1.4k 1.6× 557 0.7× 394 1.0× 126 5.5k
Dooil Jeoung South Korea 42 3.0k 1.2× 967 1.0× 693 0.8× 1.1k 1.4× 304 0.8× 166 4.8k
Ming‐Hsien Chien Taiwan 39 2.9k 1.1× 1.3k 1.4× 874 1.0× 503 0.7× 389 1.0× 142 4.5k
Sang‐Kyu Ye South Korea 38 2.3k 0.9× 1.0k 1.1× 1.2k 1.4× 1.1k 1.4× 249 0.7× 120 4.9k
Franca Stivala Italy 28 3.5k 1.4× 868 0.9× 1.6k 1.9× 528 0.7× 514 1.3× 58 5.4k

Countries citing papers authored by Hongmei Li

Since Specialization
Citations

This map shows the geographic impact of Hongmei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongmei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongmei Li more than expected).

Fields of papers citing papers by Hongmei Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongmei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongmei Li. The network helps show where Hongmei Li may publish in the future.

Co-authorship network of co-authors of Hongmei Li

This figure shows the co-authorship network connecting the top 25 collaborators of Hongmei Li. A scholar is included among the top collaborators of Hongmei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongmei Li. Hongmei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Tiantian, Tieming Chen, Hongmei Li, et al.. (2025). CRUcialG: Reconstruct Integrated Attack Scenario Graphs by Cyber Threat Intelligence Reports. IEEE Transactions on Dependable and Secure Computing. 22(6). 6345–6360. 2 indexed citations
2.
Li, Hongmei, et al.. (2024). Optimal relation-specific investment, financing, and the supply chain capital structure under uncertainty. International Review of Financial Analysis. 97. 103854–103854. 3 indexed citations
3.
Cui, Hao, Yang Kang, Hui Wang, et al.. (2024). Discovery of N-Phenyl-5-propyl-1H-pyrazole-3-carboxamide, with Selective Inhibition and Degradation of HDAC6 for the Treatment of Acute Liver Injury. Journal of Medicinal Chemistry. 68(1). 531–554. 2 indexed citations
4.
Wang, Lizhong, et al.. (2024). An Ingenane-Type Diterpene from Euphorbia kansui Promoted Cell Apoptosis and Macrophage Polarization via the Regulation of PKC Signaling Pathways. International Journal of Molecular Sciences. 25(18). 10123–10123. 4 indexed citations
5.
Yang, Mengyu, Hongmei Li, Tao Lu, et al.. (2024). Design, Synthesis, and Biological Evaluation of a Novel NIK Inhibitor with Anti-Inflammatory and Hepatoprotective Effects for Sepsis Treatment. Journal of Medicinal Chemistry. 67(7). 5617–5641. 7 indexed citations
6.
7.
8.
Cui, Bingbing, Yong Wang, Fan Lü, et al.. (2023). Discovery of 3-(1H-benzo[d]imidazole-2-yl)-1H-pyrazol-4 -amine derivatives as novel and potent syk inhibitors for the treatment of hematological malignancies. European Journal of Medicinal Chemistry. 258. 115597–115597. 7 indexed citations
9.
Li, Bohan, Hui Ma, Jing Zhu, et al.. (2023). Semisynthesis and anti-cancer properties of novel honokiol derivatives in human nasopharyngeal carcinoma CNE-2Z cells. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 2244694–2244694. 2 indexed citations
10.
Wang, Xianyan, et al.. (2022). FGFR2-CCDC6 fusion gene promotes the proliferation of Hucct-1 cells. Cellular and Molecular Biology. 68(6). 130–134. 1 indexed citations
11.
12.
13.
Yang, Huamei, et al.. (2021). Growth of Salmonella Enteritidis in the presence of quorum sensing signaling compounds produced by Pseudomonas aeruginosa. International Journal of Food Engineering. 17(12). 959–968. 1 indexed citations
14.
15.
Li, Hongmei, Li Yang, Rong Fu, et al.. (2020). A potent CBP/p300-Snail interaction inhibitor suppresses tumor growth and metastasis in wild-type p53-expressing cancer. Science Advances. 6(17). eaaw8500–eaaw8500. 40 indexed citations
16.
Yu, Yuecheng, Hongmei Li, Xia Jiang, et al.. (2014). SDF-1/CXCR7 Axis Enhances Ovarian Cancer Cell Invasion by MMP-9 Expression Through p38 MAPK Pathway. DNA and Cell Biology. 33(8). 543–549. 36 indexed citations
17.
Li, Hongmei, Jian‐Xin Pu, Xiao‐Nian Li, et al.. (2011). Four New Dibenzocyclooctadiene Lignans from Schisandra rubriflora. Chinese Journal of Natural Medicines. 91(6). 167–172. 2 indexed citations
18.
Li, Hongmei & Xiumei Wang. (2010). Second-line Treatment with Gefitinib or Docetaxel for Advanced Non-small Cell Lung Cancer. Clinical Oncology and Cancer Research. 4 indexed citations
19.
Li, Hongmei, et al.. (2007). Spectroscopic investigation of inner filter effect by magnolol solutions. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 68(5). 1263–1268. 25 indexed citations
20.
Zheng, Chengchao, Guodong Yang, Dan Wang, & Hongmei Li. (2002). [Identification and tissue-specific expression of a full length cDNA encoding ZIP protein in Arabidopsis].. PubMed. 34(1). 109–12. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Borhane Annabi Breakdown of academic impact, for papers by Yangfu Jiang Breakdown of academic impact, for papers by Chiao‐Wen Lin Breakdown of academic impact, for papers by Haiying Chen Breakdown of academic impact, for papers by Sanjay Kumar Breakdown of academic impact, for papers by Aree Moon Breakdown of academic impact, for papers by Dooil Jeoung Breakdown of academic impact, for papers by Ming‐Hsien Chien Breakdown of academic impact, for papers by Sang‐Kyu Ye Breakdown of academic impact, for papers by Franca Stivala
Rankless by CCL
2026